Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Brain and Behavior|December 7, 2021
Negative valence of hallucinatory voices as predictor of cortical glutamatergic metabolite levels in schizophrenia patientsHelene Hjelmervik, Alexander R Craven, Erik Johnsen, et al.
Psychiatry Research|October 17, 2017
The Beliefs about Voices Questionnaire - Revised: A factor structure from 450 participantsClara Strauss, Kenneth Hugdahl, Flavie Waters, et al.
Schizophrenia Research|December 20, 2015
Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119)Siri Helle, Petter Andreas Ringen, Ingrid Melle, et al.
Journal of Addictive Diseases|March 31, 2022
Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrationsFatemeh Chalabianloo, Gudrun Høiseth, Jørn Henrik Vold, et al.
BMC Infectious Diseases|November 10, 2019
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, et al.
Plos Medicine|June 1, 2021
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, et al.
Schizophrenia Research|February 4, 2026
Neural and vascular cellular adhesion molecules are associated with cognitive function in patients with schizophrenia-spectrum disorders: A longitudinal studyKristian Varden Gjerde, Christoffer Bartz-Johannessen, Else-Marie Løberg, et al.
Journal of Clinical Psychopharmacology|April 21, 2023
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)Eirik Kjelby, Rolf Gjestad, Farivar Fathian, et al.
Schizophrenia Research|February 8, 2022
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosisFarivar Fathian, Rolf Gjestad, Rune A Kroken, et al.
Trials|January 3, 2025
Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BARFatemeh Chalabianloo, Lars Thore Fadnes, Jörg Assmus, et al.
Pageof 9